<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="114344">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01958567</url>
  </required_header>
  <id_info>
    <org_study_id>TEC 125</org_study_id>
    <secondary_id>TEC 2013-006  [THE EYE CENTER]</secondary_id>
    <nct_id>NCT01958567</nct_id>
  </id_info>
  <brief_title>Optical Coherence Tomography in the Diagnosis of Scleritis and Episcleritis</brief_title>
  <official_title>Optical Coherence Tomography in the Diagnosis of Scleritis and Episcleritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Eye Center and The Eye Foundation for Research in Ophthalmology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Eye Center and The Eye Foundation for Research in Ophthalmology</source>
  <oversight_info>
    <authority>Saudi Arabia: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to describe the optical coherence tomography (OCT)
      findings in eyes with scleral inflammation and to differentiate cases with anterior
      scleritis from those with episcleritis and normal controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 40 eyes will be included. 20 eyes with scleral inflammation and 20 eyes from
      healthy subjects as controls. Each patient will undergo complete ophthalmic and medical
      examination. Laboratory studies will performed whenever indicated. Optical coherence
      tomography B-scans of the sclera in the perilimbal area will done for all cases.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>To describe the optical coherence tomography (OCT) findings in eyes with scleral inflammation</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>To differentiate cases with anterior scleritis from those with episcleritis and normal controls</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Scleritis and Episcleritis</condition>
  <arm_group>
    <arm_group_label>Patients with clinical signs of scleritis or episcleritis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Optical Coherence Tomography for patients with scleral inflammation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal subjects with normal sclera</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Optical Coherence Tomography on eyes with normal scleral</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Optical Coherence Tomography</intervention_name>
    <arm_group_label>Patients with clinical signs of scleritis or episcleritis</arm_group_label>
    <arm_group_label>Normal subjects with normal sclera</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over the age of 18 years any gender

          -  Patients with clinical signs of scleritis or episcleritis

          -  Signed informed consent

        Exclusion Criteria:

          -  Infectious keratitis or conjunctivitis

          -  Patients 18 years or younger

          -  Inability to open the eye
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Samir Shawky Shoughy</last_name>
    <phone>0096614649614</phone>
    <email>samir.shawki@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Khalid Fouad Tabbara</last_name>
    <phone>0096614649614</phone>
    <email>k.tabbara@nesma.net.sa</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Eye Center</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 7, 2013</lastchanged_date>
  <firstreceived_date>October 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Eye Center and The Eye Foundation for Research in Ophthalmology</investigator_affiliation>
    <investigator_full_name>Samir S. Shoughy, MD, FRCS (Glasg.)</investigator_full_name>
    <investigator_title>Ophthalmologist</investigator_title>
  </responsible_party>
  <keyword>Scleritis</keyword>
  <keyword>Episcleritis</keyword>
  <keyword>Optical coherence Tomography</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Scleritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
